NCT Number: NCT00468962
The Effct of Chitooligosaccharide on Immune Function in Healthy Adults
Functional properties of chitooligosaccharides have been studied for antitumor activity, immunostimulating effects, antimicrobial activity, free radical scavening activity, adn angiotensin I converting enzyme inhibitory activity. Recent in vitro, and in vivo toxicity and absorbability studies have demonstrated that chitooligosaccharides have high absorbability and are essentially non-toxic. In the present study, we prepared a chitooligosaccharide with high absorbability and evaluated its effects on activation of immune function and cardiovascular funciton(lipid, atrial stiffness, etc) in healthy adults.
This study was a 8-week, randomized, double-blind clinical trial. The 30 volunteers were divided into a control group(n=10), half dose chitooligosaccaride(FACOSTM) intake group(n=10), and full dose FACOS intake group(n=10). Peripheral blood mononuclear cells(PBMCs) were isolated and cultured in 12 well plate for 48 hours. Cytokine production by PBMCs pre- and postintervention were measured simultaneously after stimulation with lipopolysaccaride.
Looking for future studies?
Notify MeKey information
Conditions
Age range
20 year–50 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 4
Who can participate
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- healthy adults(the ages between 20~50 year)
Exclusion criteria
- food allergy and allergy skin disease
- severe liver and kidney disease
- pregnant, lactating women
- cancer, stroke, etc.
Treatment and study plan
Sponsors and collaborators
Lead sponsor
Eulji University Hospital
Other
Registry information
Important dates
- First posted
- May 3, 2007
- Registry last updated
- May 3, 2007
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Related clinical trials
Published trials that share one or more normalized conditions with this study.
Effects of LP28 on Immunity Enhancement in the Elderly
NCT06724185
Common Cold, Immunity
Taichung, Taiwan
View Trial DetailsAnalysis of Psychoneuroimmunological Parameters of Health in Specific Population Groups in Slovakia
NCT07070180
Adverse Childhood Experience, Anxiety Disorders
Bratislava, Slovakia
View Trial DetailsPFAS Exposure and Immune Response to Vaccination in Adults
NCT06588530
Actinomycetales Infections, Adult
Paulsboro, New Jersey, United States
View Trial DetailsEfficacy of Twinkle Eyez Supplementation in Improving Ocular Health and Immunity
NCT06574685
Dry Eye Disease, Dry Eye Syndromes
Cheras, Kuala Lumpur, Malaysia
View Trial Details